Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.

Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.

Item
http://www.wikidata.org/entity/Q35806170
Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.Dose escalation studies with caspofungin against Candida glabrata.Blad-Containing Oligomer Fungicidal Activity on Human Pathogenic Yeasts. From the Outside to the Inside of the Target Cell.The evolving role of antifungal susceptibility testing.Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris.Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report.In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infectionCaspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpointsUse of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria.Filter Adsorption of Anidulafungin to a Polysulfone-Based Hemofilter During CVVHD In Vitro.Review on fungal enzyme inhibitors – potential drug targets to manage human fungal infectionsBiguanides enhance antifungal activity against Candida glabrata
P2860

Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.

Item
http://www.wikidata.org/entity/Q35806170
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Comparative effects of micafun ...... ic pathogen, Candida glabrata.
@ast
Comparative effects of micafun ...... ic pathogen, Candida glabrata.
@en
type
label
Comparative effects of micafun ...... ic pathogen, Candida glabrata.
@ast
Comparative effects of micafun ...... ic pathogen, Candida glabrata.
@en
prefLabel
Comparative effects of micafun ...... ic pathogen, Candida glabrata.
@ast
Comparative effects of micafun ...... ic pathogen, Candida glabrata.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Comparative effects of micafun ...... ic pathogen, Candida glabrata.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932